Does cordyceps have an effect on cardiomyopathy?

Written by Chen Tian Hua
Cardiology
Updated on May 26, 2025
00:00
00:00

Eating cordyceps has no scientifically proven therapeutic effect on cardiomyopathy. However, people with cardiomyopathy can appropriately consume some cordyceps without adverse effects on their condition. Moreover, cordyceps can regulate the body's immune ability and has certain anti-fatigue effects, which can still have beneficial impacts on the patient's health. Patients with cardiomyopathy should undergo long-term treatment based on their underlying heart disease. Different types of cardiomyopathy require different treatment measures. For example, patients with dilated cardiomyopathy need to be treated long-term with drugs that inhibit myocardial remodeling to improve prognosis. If heart failure occurs, treatment for heart failure should be given to improve the symptoms of heart failure.

Other Voices

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
52sec home-news-image

The difference between cardiomyopathy and coronary heart disease

Cardiomyopathy refers to a type of disease characterized primarily by organic changes in the myocardium, such as dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. These diseases are characterized mainly by pathological changes in the myocardium itself, forming a category of heart diseases. In contrast, coronary heart disease often refers to a type of heart disease caused by the narrowing of the coronary arteries due to atherosclerosis, leading to insufficient blood supply to the heart. Cardiomyopathy often manifests as damage to the myocardium, while coronary heart disease often manifests as blockage of the blood vessels. This is the fundamental difference between these two categories of heart diseases.

doctor image
home-news-image
Written by Liu Ying
Cardiology
1min 15sec home-news-image

What should be noted for dilated cardiomyopathy?

Patients with dilated cardiomyopathy should actively look for the cause of the disease and provide corresponding treatments, such as controlling infections, strictly limiting or abstaining from alcohol, treating relevant endocrine or autoimmune diseases, correcting electrolyte disorders, and improving nutritional imbalances, etc. In the early stages of dilated cardiomyopathy, although there is already enlargement of the heart and impairment of contractile function, there are no clinical manifestations of heart failure. At this stage, early pharmacological intervention should be actively implemented to slow down ventricular remodeling and further damage to the myocardium, delaying the progression of the disease. As the condition progresses, the patient's ventricular contractile function further decreases and clinical manifestations of heart failure appear. At this point, treatment should follow the guidelines for chronic heart failure. However, the specifics of the treatment and the choice of medication should be determined by a specialist based on the patient’s condition.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
52sec home-news-image

Do you have to take medication for life for dilated cardiomyopathy?

Dilated cardiomyopathy refers to a disease characterized by an enlarged heart, especially significant enlargement of the left ventricle, along with a severe reduction in the heart's ejection fraction. Those diagnosed with dilated cardiomyopathy generally require long-term, and possibly lifelong, medication management. This includes diuretic medications such as furosemide or spironolactone, and β-blocker agents such as metoprolol or bisoprolol. These medications can effectively improve symptoms of heart failure caused by dilated cardiomyopathy, enhance quality of life, and even extend lifespan. Therefore, it is crucial for patients with dilated cardiomyopathy to take medications as prescribed by a doctor and not to discontinue them arbitrarily.

doctor image
home-news-image
Written by Liu Yong
Cardiology
1min 1sec home-news-image

Late-stage symptoms of dilated cardiomyopathy

The so-called advanced stage refers to a phase where cardiac function has reached stage four. The common clinical manifestations of this stage are primarily those of heart failure, such as chest tightness and shortness of breath after activity, inability to lie flat at night, general edema, and even accumulation of fluid in the chest and abdominal cavity. Some patients with severe edema might experience abdominal distension, poor appetite, and even malnutrition, which are all manifestations of heart failure. Once cardiac function reaches stage four, patients with dilated cardiomyopathy are highly susceptible to malignant arrhythmias, such as ventricular tachycardia and ventricular fibrillation. These types of arrhythmias are a common cause of death in the late stages of dilated cardiomyopathy. Therefore, proactive prevention is crucial for these patients as they have a very poor prognosis, and it is essential to maintain active communication with their families.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 38sec home-news-image

How is hypertrophic cardiomyopathy treated?

The treatment of hypertrophic cardiomyopathy aims to improve symptoms, reduce complications, and prevent sudden death. The methods include improving ventricular compliance by reducing outflow tract obstruction, preventing thromboembolic events, and identifying high-risk patients for sudden death. Treatment needs to be individualized, and the main treatments include the following aspects: 1. Medication treatment. Drug treatment is fundamental, and drugs targeting outflow tract obstruction mainly include receptor blockers and non-dihydropyridine calcium channel blockers. For patients with congestive heart failure, targeted treatment is required. Anticoagulation treatment is necessary for patients with atrial fibrillation, and it is worth noting that for patients with chest discomfort, care should be taken to exclude outflow tract obstruction when using nitrate drugs to avoid exacerbation after use. Non-drug treatments include: 1. Surgical treatment: For patients with ineffective drug treatment and heart function class three to four, if there is severe outflow tract obstruction, septal myectomy should be considered. Currently, surgery is listed as the preferred treatment for suitable patients in consensus guidelines in both America and Europe. 2. Alcohol septal ablation; 3. Pacing therapy.